Valuation: Boston Scientific Corporation

Market Cap 65.77B 57.77B 53.72B 49.3B 92.62B 6,334B 94.05B 638B 249B 3,114B 247B 242B 10,766B P/E 2026 *
15.8x
P/E 2027 * 15.4x
Enterprise Value 72.33B 63.53B 59.08B 54.21B 102B 6,965B 103B 702B 274B 3,424B 272B 266B 11,840B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 2.97x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+1.54%
1 week+0.50%
Current month+3.68%
1 month-0.47%
3 months-28.71%
6 months-52.17%
Current year-53.59%
1 week 42.5
Extreme 42.5
44.71
1 month 42.2
Extreme 42.2
46.37
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
28/05/26 Don

Chief Executive Officer

-386,755 0.0261%
20/05/26 Buy

Director

3,580 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+0.50%-58.34%-15.18% 65.77B
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-1.41%+3.99%+80.31%+3.20% 29.37B
-2.22%-3.95%-21.09%-24.87% 27.56B
Average -0.29%+0.03%+0.69%-6.10% 75.57B
Weighted average by Cap. -0.09%+0.21%-2.10%-6.71%

Financials

2026 *2027 *
Net sales 21.57B 18.95B 17.62B 16.17B 30.38B 2,078B 30.85B 209B 81.75B 1,021B 80.99B 79.24B 3,531B 23.32B 20.49B 19.05B 17.48B 32.85B 2,246B 33.35B 226B 88.38B 1,104B 87.56B 85.67B 3,818B
Net income 3.94B 3.46B 3.22B 2.95B 5.55B 379B 5.63B 38.22B 14.93B 187B 14.79B 14.47B 645B 4.13B 3.63B 3.38B 3.1B 5.82B 398B 5.91B 40.09B 15.66B 196B 15.52B 15.18B 677B
Net Debt 6.56B 5.76B 5.36B 4.92B 9.24B 632B 9.38B 63.61B 24.85B 310B 24.62B 24.09B 1,074B 3.43B 3.01B 2.8B 2.57B 4.82B 330B 4.9B 33.23B 12.98B 162B 12.86B 12.58B 561B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
24/07/26 $44.25 +1.54% 20,689,854
23/07/26 $43.58 +1.42% 16,535,740
22/07/26 $42.97 -0.51% 11,201,174
21/07/26 $43.19 -1.33% 25,009,837
20/07/26 $43.77 -0.59% 13,129,888
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
44.25USD
Average target price
72.43USD
Spread / Average Target
+63.68%

Quarterly revenue - Rate of surprise